Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Laruparetigene zovaparvovec by Beacon Therapeutics for Retinitis Pigmentosa (Retinitis): Likelihood of Approval
Laruparetigene zovaparvovec is under clinical development by Beacon Therapeutics and currently in Phase III for Retinitis Pigmentosa (Retinitis). According to...